These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8122866)

  • 41. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
    J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical study of the action of dobutamine in acute cardiac insufficiency].
    Chevalier P; Leylavergne J; Gournay G; Laffay N; Gryman R; Renault C; Guérot C; Valère PE; Tricot R
    Ann Cardiol Angeiol (Paris); 1984; 33(4):227-32. PubMed ID: 6147116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heart rate variability in dilated cardiomyopathy.
    Biswas PK; Basu S; Mitra KK; Chowdhury SP; Chatterjee BP; Das Biswas A; Chatterjee SS; Maity AK
    Indian Heart J; 2000; 52(2):187-91. PubMed ID: 10893896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
    Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. First clinical trial with etomoxir in patients with chronic congestive heart failure.
    Schmidt-Schweda S; Holubarsch C
    Clin Sci (Lond); 2000 Jul; 99(1):27-35. PubMed ID: 10887055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of intermittent dobutamine infusion in congestive heart failure.
    Mauro VF; Mauro LS
    Drug Intell Clin Pharm; 1986 Dec; 20(12):919-24. PubMed ID: 3545732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
    Capomolla S; Febo O; Opasich C; Guazzotti G; Caporotondi A; La Rovere MT; Gnemmi M; Mortara A; Vona M; Pinna GD; Maestri R; Cobelli F
    Eur J Heart Fail; 2001 Oct; 3(5):601-10. PubMed ID: 11595609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tolerance development during a 1-week course of dobutamine treatment].
    Erlemeier HH; Kupper W; Hamm CW; Bleifeld W
    Dtsch Med Wochenschr; 1986 Jun; 111(26):1010-6. PubMed ID: 3720553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is intermittent dobutamine infusion useful in the treatment of patients with refractory congestive heart failure?
    Stecy P; Gunnar RM
    Cardiovasc Clin; 1990; 21(1):277-89; discussion 290-1. PubMed ID: 2199053
    [No Abstract]   [Full Text] [Related]  

  • 50. Dobutamine infusion for the treatment of congestive heart failure in the home care setting.
    Coffin MR
    J Intraven Nurs; 1994; 17(3):145-50. PubMed ID: 8064499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.
    Applefeld MM; Newman KA; Sutton FJ; Reed WP; Roffman DS; Talesnick BS; Grove WR
    Am Heart J; 1987 Sep; 114(3):589-95. PubMed ID: 3630900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical effects of the infusion of dobutamine and amrinone in patients with refractory cardiac insufficiency].
    Corbalán R; Martínez A; Illanes G; Jalil J; Chamorro G; Casanegra P
    Rev Med Chil; 1987 Dec; 115(12):1130-8. PubMed ID: 3332922
    [No Abstract]   [Full Text] [Related]  

  • 53. Review of intermittent dobutamine infusions for congestive cardiomyopathy.
    Thomas RL; Watson D; Marshall LE
    Pharmacotherapy; 1987; 7(2):47-53. PubMed ID: 3299303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outpatient use of dobutamine to support patients awaiting heart transplantation.
    Miller LW; Merkle EJ; Jennison SH
    J Heart Lung Transplant; 1994; 13(4):S126-9. PubMed ID: 7947869
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of chronic heart insufficiency with dobutamine. Value and limitations].
    Gibelin P; Bossan P; Ferrari E; Drici M; Morand P
    Presse Med; 1992 Oct; 21(35):1680-4. PubMed ID: 1480569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure.
    Krell MJ; Kline EM; Bates ER; Hodgson JM; Dilworth LR; Laufer N; Vogel RA; Pitt B
    Am Heart J; 1986 Oct; 112(4):787-91. PubMed ID: 3766379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral enoximone as a substitute for intravenous catecholamine support in end-stage congestive heart failure.
    Jondeau G; Dubourg O; Delorme G; Arnal JF; Chikli F; Kamoun L; Dumas C; Bourdarias JP
    Eur Heart J; 1994 Feb; 15(2):242-6. PubMed ID: 8005127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dobutamine rescue for intractable CHF.
    Schactman M; Crawford MV
    Am J Nurs; 1988 Dec; 88(12):1642-3. PubMed ID: 3195632
    [No Abstract]   [Full Text] [Related]  

  • 59. Intermittent dobutamine infusion in severe chronic heart failure in elderly patients.
    Van den Brande P; Van Mieghem W; Demedts M
    Gerontology; 1990; 36(1):49-54. PubMed ID: 2384225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preliminary evidence for the mechanism underlying the development of tolerance to prazosin in congestive heart failure: the alpha-agonistic properties of dobutamine unmasked by prazosin treatment.
    Kersting F; Kupp M; Giesen G
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):537-43. PubMed ID: 7681897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.